Latest Lead News

Apiam Animal Health Limited shareholders are set to vote on a scheme of arrangement offering $0.87 cash per share or a mix of cash and unlisted scrip in a new holding company controlled by Adamantem Capital. The Independent Expert deems the cash offer fair and reasonable, while scrip options carry liquidity and minority risks.

Minbos Resources has launched a prospectus offering nearly 118 million free attaching options to recent Placement investors, aiming to bolster funding for its Cabinda fertilizer plant amid operational and geopolitical challenges in Angola.

Korab Resources reports significant gold and base metals exploration progress at its Rum Jungle Project, alongside innovative mining method evaluations and ongoing legal challenges to key lease renewals.

GenusPlus Group, partnering with ACCIONA, has won a $1.6 billion contract to build Victoria’s Western Renewables Link, a major transmission project set to power up to one million homes with renewable energy.

Goodman Group has announced an estimated ordinary dividend of AUD 0.15 per security for the six months ending December 2025, with payment scheduled for February 2026. The dividend is unfranked, and final details will be confirmed in February.

Amplitude Energy has addressed an ASX query regarding the delayed filing of a director’s interest change, attributing it to an administrative oversight while affirming its compliance framework.

Medallion Metals has completed a Feasibility Study for its Ravensthorpe Gold Project, confirming robust economics and a clear pathway to near-term gold and copper production leveraging existing infrastructure in Western Australia.

An independent meta-analysis presented at the ASH Annual Meeting reveals Mesoblast’s remestemcel-L achieves superior remission rates and safety outcomes compared to ruxolitinib in treating steroid-refractory acute graft-versus-host disease.

ABx Group has secured a new five-year exploration licence in northern Tasmania, expanding its rare earths tenure between key deposits and advancing its high-value rare earth product development.

National Storage REIT has announced a fully franked 6 cent dividend for the second half of 2025, while withdrawing all prior guidance due to a significant scheme announcement.

Rhythm Biosciences has begun commercialising ColoSTAT®, its blood-based colorectal cancer diagnostic test, following an updated ISO15189, 2022 accreditation. The test offers a new option for symptomatic patients where stool-based screening is unsuitable.

HITIQ has secured a prestigious grant from the Australian Sports Commission to enhance its PROTEQT™ brain health monitoring technology, positioning the company for wider adoption across elite and community sports.